EUVIMEDEUVIMED entdecken
Open Access

Upregulation of Sox2 Following Saracatinib Treatment Contributes to a Resistant Phenotype in Colorectal Cancer Cells under Growth Factor-Supplemented Conditions

Chanwoong Yoon, Euihyeon Na, Min Joo Choi, Sang-Pil Yoon

Oncology Research · 2026

DOI: 10.32604/or.2026.074140 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Oncology Research, 2026. Verfasst von Chanwoong Yoon und 3 weiteren Autor:innen. Beteiligte Einrichtung: Interdisciplinary Postgraduate Program in Biomedical Engineering, Graduate School, Jeju National University, Jeju, Republic of Korea. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Drug Resistance, Neoplasm, Quinazolines, Benzodioxoles. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Colorectal NeoplasmsDrug Resistance, NeoplasmQuinazolinesBenzodioxolesSOXB1 Transcription FactorsHumansCell Line, TumorUp-RegulationCell MovementSpheroids, CellularGene Expression Regulation, NeoplasticCell SurvivalApoptosisFluorouracilNeoplastic Stem CellsProtein Kinase InhibitorsPhenotypeSignal TransductionCell Proliferation

Stichwörter der Autor:innen

Src inhibitorcolorectal cancerdrug resistanceepithelial-mesenchymal transitionsex determining region Y-box-2

Substanzen

QuinazolinesBenzodioxolesSOXB1 Transcription FactorssaracatinibSOX2 protein, humanFluorouracilProtein Kinase Inhibitors

Autor:innen und Institutionen

  • Interdisciplinary Postgraduate Program in Biomedical Engineering, Graduate School, Jeju National University, Jeju, Republic of Korea.
  • Department of Psychiatry, Soonchunhyang University Cheonan Hospital, Soonchunhyang University College of Medicine, Cheonan, Republic of Korea.
  • Department of Anatomy, College of Medicine, Jeju National University, Jeju, Republic of Korea.

Zitieren

APA

Yoon, C., Na, E., Choi, M. J., & Yoon, S. P. (2026). Upregulation of Sox2 Following Saracatinib Treatment Contributes to a Resistant Phenotype in Colorectal Cancer Cells under Growth Factor-Supplemented Conditions. Oncology Research. https://doi.org/10.32604/or.2026.074140

Vancouver

Yoon C, Na E, Choi MJ, Yoon SP. Upregulation of Sox2 Following Saracatinib Treatment Contributes to a Resistant Phenotype in Colorectal Cancer Cells under Growth Factor-Supplemented Conditions. Oncology Research. 2026. doi:10.32604/or.2026.074140

BibTeX
@article{Yoon2026,
  author = {Yoon, Chanwoong and Na, Euihyeon and Choi, Min Joo and Yoon, Sang-Pil},
  title = {Upregulation of Sox2 Following Saracatinib Treatment Contributes to a Resistant Phenotype in Colorectal Cancer Cells under Growth Factor-Supplemented Conditions},
  journal = {Oncology Research},
  year = {2026},
  doi = {10.32604/or.2026.074140}
}
Kostenlos starten →